| Product Name | MF | CAS | Details |
|---|
| ALW-II-41-27 - Bio-X ? | C32H32F3N5O2S | 1186206-79-0 | Details |
| SLC16A1 antibody | Details |
| MK-0941 | C21H24N4O6S | 752240-01-0 | Details |
| Venoterpine | C9H11NO | 17948-42-4 | Details |
| 6,7-Difluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | C9H10ClF2N | 1909328-05-7 | Details |
| (1,3-Thiazol-2-yl)methanamine | C4H6N2S | 55661-33-1 | Details |
| Methyl 2-hydrazinecarboxylate | C4H8ClN3O2 | 1185503-26-7 | Details |
| 2,6-Dichloroindophenol sodium salt hydrate | C12H10Cl2NNaO3 | 1266615-56-8 | Details |
| GAA antibody | Details |
| 2-(1-Benzofuran-2-carbonyl)pyridine | C14H9NO2 | 17557-42-5 | Details |
| 7-Methylidene-4-azaspiro[2.5]octane | 2243515-40-2 | Details |
| 7-Nitro-3,4-dihydro-1,4-benzoxazepin-5(2H)-one | C9H8N2O4 | 21228-43-3 | Details |
| (S)-(-)-2-Pyrrolidone-5-carboxylic acid | C5H7NO3 | 98-79-3 | Details |
| 2-Amino-2-(3-(trifluoromethyl)phenyl)propanoic acid hydrochloride | C10H11ClF3NO2 | 1251925-11-7 | Details |
| 2-Methyl-N-(octahydroindolizin-1-yl)cyclopropane-1-carboxamide | C13H22N2O | 1311712-10-3 | Details |
| PH-002 | C27H33N5O4 | 1311174-68-1 | Details |
| 2-{[(9H-Fluoren-9-ylmethoxy)carbonyl][(3-methylphenyl)methyl]amino}acetic acid | C25H23NO4 | 2138196-65-1 | Details |
| tert-Butyl 4-hydroxy-4-(3-methoxyphenyl)piperidine-1-carboxylate | C17H25NO4 | 871112-35-5 | Details |
| 1H-Pyrazole | C3H4N2 | 288-13-1 | Details |
| (Deamino-Cys1,b-(3-pyridyl)-D-Ala2,Arg8)-Vasopressin trifluoroacetate salt | C45H63N15O11S2 | 136105-89-0 | Details |
| Tulrampator | C20H17FN4O3 | 1038984-31-4 | Details |
| NOC4L antibody | Details |
| 1-(4-Chloro-3-trifluoromethylphenyl)-3-(4-hydroxyphenyl)urea | C14H10ClF3N2O2 | 1129683-83-5 | Details |
| Biotin-Secretin, human | Details |
| 4-[(2-Oxopyrrolidin-1-yl)methyl]benzonitrile | C12H12N2O | 1017045-93-0 | Details |
| 1-Ethyl-1H-1,2,3-triazole-4-carboxylic acid | C5H7N3O2 | 1211541-99-9 | Details |
| Ethyl boronic acid | C2H7BO2 | 4433-63-0 | Details |
| IL22 antibody | Details |
| Methyl-3-[5-(2-methoxycarbonylethyl)pyrazin-2-yl]propionate | C12H16N2O4 | 77479-01-7 | Details |
| 3-Amino-2-methyl-3-phenylpropanoic acid hydrochloride | C10H13NO2.ClH | 180182-02-9 | Details |
| 3-N-Boc-aminomethyl pyrrolidine | C10H20N2O2 | 149366-79-0 | Details |
| VH 101, phenol | C26H33FN4O5S | 2306193-99-5 | Details |
| 2-Ethylhexanoyl tert-butyl peroxide | C12H24O3 | 3006-82-4 | Details |
| 1,6-Hexanediol dimethacrylate - stabilized with MEHQ | C14H22O4 | 6606-59-3 | Details |
| JW 67 | C21H18N2O6 | 442644-28-2 | Details |
| H-ATVVYQGER^-OH | Details |
| 2-Undecylimidazole | C14H26N2 | 16731-68-3 | Details |
| NE 52-QQ57 | C24H28N6O | 1401728-56-0 | Details |
| Ulixertinib hydrochloride | C21H23Cl3N4O2 | 1956366-10-1 | Details |
| 4-{5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl}-1,3-thiazol-2-amine | C10H7BrN4S | 868387-43-3 | Details |
| 3,3-Dimethyl-2-benzofuran-1(3H)-one | C10H10O2 | 1689-09-4 | Details |
| (2,6-difluorophenyl)-N-(6-ethoxybenzothiazol-2-yl)formamide | C16H12F2N2O2S | 476277-40-4 | Details |
| 5-Amino-6-hydroxy-1,3-dimethyl-2,3-dihydro-1H-1,3-benzodiazol-2-one | C9H11N3O2 | 101654-72-2 | Details |
| 5-Bromo-[2,3']bipyridinyl | C10H7BrN2 | 774-53-8 | Details |
| Ethyl 4-oxo-1,4-dihydrocinnoline-3-carboxylate | C11H10N2O3 | 219568-43-1 | Details |
| Ethyl 2,5-dimethyl-1,3-thiazole-4-carboxylate hydrobromide | C8H12BrNO2S | 1803610-34-5 | Details |
| tert-Butyl N-[(1S,5R)-3-Azabicyclo[3.1.0]hexan-6-yl]carbamate | C10H18N2O2 | 134575-17-0 | Details |
| Vn96 Peptide or venceremin, patent WO 2012/126118 | Details |
| Beclotiamine hydrochloride | C12H17Cl3N4S | 7275-24-3 | Details |
| 2-[[(4-Chloro-3-methyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole | C14H12ClN3OS | 168167-42-8 | Details |
| 2-Chloro-6-fluorobenzoic acid methyl ester | C8H6ClFO2 | 151360-57-5 | Details |
| Affinity Purified Goat anti-Mouse IgG, IgM, IgAminimal reactivity with Human | Details |
| For-Nle-Leu-Phe-Nle-Tyr-Lys-OH | C43H65N7O9 | 71901-21-8 | Details |
| AFG3L2 antibody (FITC) | Details |
| 2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-D-gluconhydroximo-1,5-lactone | C16H22N2O10 | 132152-77-3 | Details |
| 5-[(Dimethylamino)methyl]pyridin-3-amine | C8H13N3 | 1403249-01-3 | Details |
| N-[1-(4-Bromo-2-fluorophenyl)ethylidene]hydroxylamine | C8H7BrFNO | 912341-93-6 | Details |
| 7-Methoxy-2-methyl-3,10-diazatricyclo[6.4.1.0,4,13]trideca-1,4,6,8(13)-tetraene | C13H16N2O | 1707367-39-2 | Details |
| Demethyl Salvinorin-HRP | Details |
| Anthopleurin-A | C215H326N62O67S6 | 60880-63-9 | Details |
| Equol-7,4'-dimethyl ether | C17H18O3 | 4366-35-2 | Details |
| Biot-GPR-OH | Details |
| 6-Bromo-3-(2-methoxyethyl)-2-sulfanyl-3,4-dihydroquinazolin-4-one | C11H11BrN2O2S | 854036-05-8 | Details |
| 3-[(4-Aminophenyl)sulfanyl]propan-1-ol | C9H13NOS | 602306-71-8 | Details |
| 3-Chloro-4-methoxybenzoic acid ethyl ester | C10H11ClO3 | 14670-04-3 | Details |
| 2,4,6-Triethylbenzene-1-sulfonyl chloride | C12H17ClO2S | 115472-98-5 | Details |
| 3-(Chloromethyl)-4-methyl-1H-pyrazole hydrochloride | C5H8Cl2N2 | 2095410-54-9 | Details |
| 1-(1,1-Difluoroethyl)-4-nitrobenzene | C8H7F2NO2 | 32471-55-9 | Details |
| 2-Amino-1-(3-methoxyphenyl)propan-1-ol hydrochloride | C10H16ClNO2 | 1005002-76-5 | Details |
| Ethynyl estradiol 17-acetate-3-(2',3',4'-tri-O-acetyl-b-D-glucuronide) methyl ester | C35H42O12 | 242130-33-2 | Details |
| tert-Butyl 7-hydroxy-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxylate | C13H16N2O4 | 1824074-89-6 | Details |
| 2-(2,3-dichlorophenoxy)-N-(((phenylamino)thioxomethyl)amino)ethanamide | C15H13Cl2N3O2S | 1020252-10-1 | Details |
| 5-Fluoropyridine-2-boronic acid | C5H5BFNO2 | 946002-10-4 | Details |
| H-VIVMLTPLV-OH | Details |
| (R)-1-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pyrrolidin-3-ol | C15H23BN2O3 | 1225066-77-2 | Details |
| BLOC1 antibody (FITC) | Details |
| 5-Bromoimidazo[2,1-b][1,3]thiazole-2-carboxylic acid | C6H3BrN2O2S | 1550302-03-8 | Details |
| H-PAYRPPNAPIL-OH | Details |
| H-HLVEALYLV-OH | Details |
| H-SLAFEEGSQSTTISS-OH | Details |
| 4-(6-Oxopiperidin-2-yl)butanoic acid | C9H15NO3 | 90942-98-6 | Details |
| CAMK2N2 protein (His tag) | Details |
| Tetramethylammonium hydrogensulfate hydrate | C4H15NO5S | 207738-07-6 | Details |
| Goat anti Rabbit IgG (H + L) (Fab'2) | Details |
| Cyclin B1 antibody (Ser126) | Details |
| 5-(Propan-2-yl)-1,3,4-oxadiazole-2-thiol | C5H8N2OS | 1711-73-5 | Details |
| (1S)-1-(5,6,7,8-Tetrahydronaphthalen-2-yl)ethan-1-amine hydrochloride | C12H18ClN | 1461689-25-7 | Details |
| 2-Benzoyl-1,3-thiazole-4-carboxylic acid | C11H7NO3S | 1509486-15-0 | Details |
| GAB2 antibody (Ser623) | Details |
| 2-Methyl-3-[pyrrolidin-1-yl(thiophen-2-yl)methyl]-1H-indole | C18H20N2S | 618407-03-7 | Details |
| 4-Chloro-5-methylpyridine-2-carboxamide | C7H7ClN2O | 1379357-31-9 | Details |
| Cathelicidin Antimicrobial Peptide, human, recombinant | Details |
| 4-Methoxyquinoline-3-carboxylic acid | C11H9NO3 | 74557-74-7 | Details |
| TMEM138 Blocking Peptide | Details |
| Radretumab | 1253180-81-2 | Details |
| Acetic acid, rac-tert-butyl N-[(1R,4R)-4-carbamimidoylcyclohexyl]carbamate | 2137033-49-7 | Details |
| N-Methyl-2-(5-Methyl-1,2,4-Oxadiazol-3-Yl)Ethanamine Hydrochloride | C6H12ClN3O | 1255717-81-7 | Details |
| 3-Cycloheptylazetidine hydrochloride | 2138513-86-5 | Details |
| N-Ethyl-4-fluoroaniline | C8H10FN | 405-67-4 | Details |
| Octyl D-glucuronic acid | C14H26O7 | 208400-78-6 | Details |
| Product Total： Product Page： | ||||
| 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 | ||||